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Identification of fetal kidney anomalies invites questions about underlying causes and recurrence 
risk in future pregnancies. We therefore investigated the diagnostic yield of next-generation 
sequencing in fetuses with bilateral kidney anomalies and the correlation between disrupted genes 
and fetal phenotypes. 
Fetuses with bilateral kidney anomalies were screened using an in-house-designed kidney-gene 
panel. In families where candidate variants were not identified, whole-exome sequencing was 
performed. Genes uncovered by this analysis were added to our kidney-panel. 
We identified likely deleterious variants in 11 of 56 (20%) families. The kidney-gene analysis 
revealed likely deleterious variants in known kidney developmental genes in six fetuses and 
TMEM67 variants in two unrelated fetuses. Kidney histology was similar in the latter two fetuses – 
presenting a distinct prenatal form of nephronophthisis. Exome sequencing identified ROBO1 
variants in one family and a GREB1L variant in another family. GREB1L and ROBO1 were added 
to our kidney-gene panel and additional variants were identified.  
Next-generation sequencing substantially contributes to identifying causes of fetal kidney 
anomalies. Genetic causes may be supported by histological examination of the kidneys. This is the 
first time that SLIT-ROBO signaling is implicated in human bilateral kidney agenesis. 
  
 
















Fetal kidney anomalies are diagnosed more frequently now than earlier owing to the wider use of 
second-trimester ultrasound screening. Although prenatal ultrasound scans can identify kidney 
agenesis or cystic, enlarged, hypoplastic, and/or echogenic kidneys, these findings do not point 
toward a specific underlying cause. Furthermore, kidney anomalies may be accompanied by non-
urinary disease, like blindness, diabetes, and learning disability, which are un-detectable on a 
prenatal scan. Consequently, no valid overall prognosis can be made. Moreover, the diagnosis of 
severe bilateral kidney anomalies often invites considerations regarding termination of pregnancy 
and inevitably raises questions about recurrence risk in future pregnancies.  
A growing number of monogenic causes of kidney anomalies are discovered, each however 
accounting for only a minority of cases. Furthermore, many genetic underlying causes have shown 
reduced penetrance and variable expressivity (1,2). Also, environmental factors like maternal 
diabetes and drug exposures may increase the risk of fetal kidney anomalies (3,4). These 
complexities have limited recognition of novel underlying causes. However, identification of 
underlying genetic causes may significantly improve the quality of prenatal counseling.  
Previous studies on kidney anomalies using next-generation sequencing (NGS) have focused on 
specific disease entities like nephronophthisis or used broadly defined cohorts of patients with 
congenital anomalies of the kidney and urinary tract (CAKUT), also including cases with only 
minor anomalies (5-7). It is estimated that variants in protein coding sequence or copy number 
variants (CNVs), which likely explain the phenotype, can currently be identified in 10-16% of 
CAKUT patients (8). 
In this study, we investigate the diagnostic yield of targeted-gene sequencing and whole-exome 
sequencing in a well-defined cohort of autopsied fetuses with severe prenatally diagnosed bilateral 











kidney anomalies in which previous genetic analyses have not uncovered an underlying cause; and 
we correlate our genetic findings with detailed phenotypic information, including post-mortem 
kidney histology. 
 
Materials and methods 
Study population 
Eligible fetuses were identified by systematically searching local registers at departments of clinical 
genetics and departments of pathology in Aalborg, Aarhus, Odense, and at Rigshospitalet 
(Copenhagen), Denmark. To be included, the fetus should prenatally have been diagnosed with 
bilateral kidney anomalies, or unilateral kidney anomalies in combination with oligohydramnios or 
anhydramnios, indicating that the kidney affection most likely was bilateral. The pregnancy should 
be terminated upon parental request approved by a regional abortion committee. Subsequently, the 
fetuses should have undergone post-mortem examination. DNA extracted from fresh tissue or 
cultured cells from the fetus or the pregnancy should be available from at least one fetus from each 
family. From some affected fetal siblings, DNA was recovered from formalin-fixed, paraffin-
embedded tissue. 
Fetuses with additional other organ abnormalities, like major heart malformations, neural tube 
defects, and/or missing extremities, were excluded. Fetuses with anal atresia, genital malformations, 
or minor vertebra defects were not excluded as we hypothesized that the implicated organs belong 
to the same developmental field as the kidneys and that malformations in these organs may be 
caused by variants in kidney developmental genes. Moreover, we excluded fetuses already known 
to harbor genetic variants likely explaining the kidney phenotype, viz. monosomy X, 22q11 
deletion, 17q12 deletion, HNF1B variant, and PKHD1 variants, among others.  











Families with two affected fetuses whose fetal kidney anomalies remained unsolved after kidney-
gene analysis were recruited for whole-exome sequencing. Blood samples were obtained from the 
parents and other adult family members. Buccal smear samples were obtained from affected and 
non-affected live-born siblings for Sanger sequencing of candidate variants if requested by the 
parents. 
Novel genes identified by whole-exome sequencing were added to our kidney-gene panel and 
selected samples were re-analyzed. 
Kidney gene panel 
The kidney gene panel included 108 genes chosen because of their potential involvement in 
embryonic kidney development, cystic kidney disease, nephrotic syndrome, or the renin-angiotensin 
system. The list of panel genes is available in Supporting Information I. 
Sequencing and data analyses 
Genomic DNA was extracted from fetal tissue, chorion villi, amnion fluid, fibroblasts, formalin-
fixed paraffin-embedded tissue, whole blood, or buccal smear samples using standard methods. 
Kidney-gene sequencing 
A library for Illumina paired-end sequencing was constructed using the KAPA HTP Library 
Preparation Kit following the manufacturer’s instructions (KAPA Biosystems Inc., Wilmington, 
MA, USA). The libraries were enriched for regions of interest using the customized targeting probe 
set (SeqCap EZ Choice, Roche Nimblegen, Inc., Madison, WI, USA). Samples were sequenced on 
a NextSeq 500 Sequencer (Illumina, San Diego, CA, USA) generating paired-end reads that were 
aligned to the human genome (hg19), and variants were called and annotated in coding exons 10 
bp using Biomedical Genomics Workbench v.2 (CLC bio-Qiagen, Aarhus, Denmark). The average 











coverage was 698 (range: 133-1543), and the average percentage of bases covered >30X was 98.2% 
(range: 95.4%-99.9%).  
Copy number variant analysis was performed using the built-in CNV detection tool in the 
Biomedical Genomics Workbench v.2, comparing local coverage in each patient data set to local 
coverage in a set of four controls.  
Whole-exome sequencing 
Libraries were prepared as described above. The libraries were enriched for the exome using the 
SeqCap EZ MedExome Kit following the manufacturer’s instructions (Roche NimbleGen Inc., 
Madison, WI, USA). Samples were sequenced on a NextSeq 500 Sequencer (Illumina, San Diego, 
CA, USA). The reads obtained from sequencing were aligned to the human genome (hg19) and 
variants were called and annotated in coding exons 10 bp using Biomedical Genomics Workbench 
v.2 (CLC bio-Qiagen, Aarhus, Denmark).  
Across eight samples from two families, we achieved average targeted exome coverage of 119X 
with an average mapping quality of 63.6 for calling high-quality variants (Supporting Information 
II).  
Sanger sequencing 
Significant NGS findings were confirmed by Sanger sequencing using BigDye® Terminator v1.1 
Cycle Sequencing Kit following the manufacturer’s description (Applied Biosystems, Life 
Technology) and analyzed using ABI 3500xl Genetic Analyzer (Applied Biosystems, CA, USA). 
Relatives were also tested by Sanger sequencing if samples were available. Primer sequences and 
other PCR details are available upon request. 












Kidney-gene panel  
Synonymous variants were removed except for those located 2 bp off exon boundaries. Also, all 
intronic variants >10 bp from exon boundaries were removed. Furthermore, variants with a minor 
allele frequency (MAF) >1% in public databases (the Exome Aggregation Consortium (ExAC) 
database, the 1000 Genomes Project, or whole-exome sequencing of 2,000 Danish individuals) 
were removed as were variants with an MAF >5% in our in-house database. However, all frame-
shift variants and variants affecting stop codons were retained irrespectively of their MAF. The 
functional significance of the retained variants was evaluated in silico using the online prediction 
software Polyphen, Mutation Taster, Provean, Sift, CADD if applicable.  
We classified variants identified by the kidney-gene panel as likely deleterious if the MAFs were 
extremely low, they were predicted as deleterious by the majority of the prediction softwares 
applied, and the fetal phenotype had similarities with the phenotypes previously reported for 
variants in that gene. Variants thought to be benign were not reported and variants appearing in 
heterozygous form in genes associated with autosomal recessive disease were reported only if an 
additional likely deleterious variant was identified in the same gene.  
Whole-exome sequencing 
Variants identified by whole-exome sequencing were analyzed in QIAGEN’s Ingenuity® Variant 
Analysis™ (www.qiagen.com/ingenuity) software. Exome data from each family were analyzed 
separately based on the family history.  
Variant calls were removed based on default coverage and quality thresholds. Only variants outside 
very variable regions were retrained. We removed variants with an MAF ≥ 0.1% in the 1000 
Genomes Project, the National Heart Lung Blood Institute Exome Sequencing Project (NHLBI-











ESP), or the Allele Frequency Community (AFC). Variants listed in HGMD were retained. Variants 
predicted to be deleterious, frame-shift variants, in-frame indel variants, missense variants, and 
variants affecting start/stop codons were retained. We also retained variants causing splice site loss 
≤ 2 bases into introns or predicted to affect splice sites according to MaxEntScan (9). 
In Family 1 (Fig. 1a), an autosomal recessive disease entity was suspected as both fetuses had a 
syndromic presentation and both parents were unaffected. Filtering was applied to retain variants 
present in homozygous or compound heterozygous form in the affected fetus with each parent being 
a carrier. Subsequently, filtering was applied to detect variants present in heterozygous form in the 
affected fetus but not in the parents, assuming one parent has germline mosaicism. In Family 2 (Fig. 
1b), an autosomal dominant disease entity was suspected due to the observation of an affected 
mother and two affected fetuses. Filtering was applied to retain variants present in heterozygous 
form in the affected mother and the second affected fetus. Subsequently, filtering was applied to 
retrain variants present in heterozygous form only in affected but not in unaffected family members. 
For variants identified by exome sequencing, we classified variants as likely deleterious if the 
MAFs were extremely low, they were predicted as deleterious by the majority of the prediction 
softwares applied, the affected gene had a known function in kidney development, and all affected 
individuals in the family under study harboured the variant.  
Kidney histology 
Post-mortem examination was performed with informed consent in all cases. Hematoxylin and 
eosin-stained kidney and liver sections from fetuses in which we identified a likely deleterious 
variant were all re-evaluated by a fetal pathologist. 
Ethics  
The study was approved by the Danish Data Protection Agency (1-16-02-26-12). 











The Central Denmark Regional Committee of Ethics approved the kidney gene-targeted analysis 
study (1-10-72-169-14). The National Committee of Ethics approved the whole-exome sequencing 
study (1504797). Written informed consent for whole-exome sequencing was obtained from all 
included parents and adult family members. Whole-exome sequencing in live-born children was not 
approved. 
Results  
Kidney gene panel 
We included samples from 62 fetuses from 56 families. Prenatal kidney anomalies included: kidney 
agenesis, kidney hypoplasia, classic multicystic dysplastic kidneys, dysplastic kidneys, cystic 
kidneys, duplex kidney, kidney parenchymal thinning, and echogenic kidneys (Table 1). The 
male/female fetal ratio was 2.1. Eleven families had a family history of kidney anomalies. None of 
the parents were known to be consanguineous.  
Detailed information about prenatal findings, post-mortem findings, source of DNA, and previous 
genetic analyses in each fetus is presented in Supporting Information III.  
Kidney-gene analysis in fetuses from the 56 families revealed likely deleterious variants in eight 
fetuses from seven families (Table 2). No disease-associated CNVs were identified.  
The unrelated fetus 9 and fetus 53 were both affected by enlarged cystic kidneys and ductal plate 
malformations. We identified two TMEM67 variants in each. Unfortunately, it could not be 
confirmed that the variants were located on separate chromosomes.  
Fetus 11 and fetus 12 were dizygotic twins both affected by bilateral kidney hypoplasia with cystic 
dysplasia. We identified the same missense variant in PAX2 in both. The father has unilateral 











kidney agenesis, the paternal grandfather has an unknown kidney disease. Unfortunately, they were 
not available for genetic testing. 
In fetus 16, affected by isolated bilateral kidney agenesis, we identified a missense variant in 
WNT4.  
In fetus 19, post-mortem examination revealed isolated kidney affection with unilateral duplex 
kidney and cystic kidney dysplasia of the upper kidney as well as bilateral hydronephrosis. A 
missense variant in SIX2 was identified in fetus 19. 
In fetus 29, a nonsense variant was previously identified in RET: c.3148C>T p.(Arg1050*), but was 
not considered the cause of bilateral kidney agenesis at the time of identification as it was inherited 
from the healthy father. The fetus was therefore included in the present study. Next-generation 
sequencing showed no evidence of RET variant mosaicism in blood obtained from the father. 
Kidney ultrasound of the father revealed no abnormalities. He had no symptoms of Hirschsprung 
disease or multiple endocrine neoplasia type 2, nor had his immediate relatives.  
In fetus 43, affected by bilateral kidney agenesis and hypertrophic heart, we identified a missense 
variant in ROBO2 as well as a missense variant in SLIT2. 
Whole-exome sequencing 
Families with two affected fetuses were contacted for permission to perform exome sequencing. 
Two families gave informed consent.  
In Family 1, two pregnancies were terminated due to bilateral kidney agenesis. In both, post-
mortem examination confirmed the absence of both kidneys and revealed female fetuses with 
genital hypoplasia, hypoplasia of halluces, intestinal malrotation, and anteriorly displaced anus. In 
addition, one fetus was diagnosed with corpus callosum agenesis. Kidney ultrasound examinations 
in both parents and prenatal ultrasound examinations in the two live-born brothers identified no 











abnormalities. Exome sequencing in the second affected fetus, the mother, and the father revealed 
two novel likely deleterious variants in ROBO1 in the fetus. One of the variants, ROBO1 
c.4823C>G p.(Ser1608*), was also identified in the mother; the other variant, ROBO1 c.526C>T 
p.(Pro176Ser), was also identified in the father. Subsequently, Sanger sequencing identified both 
ROBO1 variants in the first affected fetus. Buccal swamp samples were obtained from the live-born 
brothers. Surprisingly, also the older brother harbored both ROBO1 variants. However, a detailed 
anamnesis and medical chart review revealed that he has dysmorphic features (frontal bossing, 
curled ears, and curled retinal arteries), chronic constipation requiring medication, nocturnal and 
diurnal enuresis, delayed motor development (he was 2 years and 3 months before walking) as well 
as delayed social and emotional development. He follows the -3 standard deviation reference curve 
for height and weight although the parents are of normal height. Array-cgh analysis and kidney 
ultrasound have been normal. The younger brother, only harbouring one ROBO1 variant, has 
normal growth and has reached developmental milestones at average age (Table 2, Fig. 1a). 
In Family 2, two pregnancies were terminated due to bilateral kidney agenesis. Post-mortem 
examination confirmed isolated absence of both kidneys in a female and in a male fetus, 
respectively. Kidney ultrasound in the parents revealed left-sided kidney agenesis in the mother and 
normal kidneys in the father. Kidney ultrasound in the maternal grandparents and maternal uncle 
disclosed no abnormalities. Kidney ultrasound examinations of the three live-born brothers were 
unremarkable. Exome sequencing in the second affected fetus, the mother, the father, and the 
maternal grandparents revealed a novel likely deleterious variant in GREB1L (c.5608+1del) in the 
mother and the second affected fetus. The same variant was identified in the first affected fetus and 
in the two eldest live-born brothers using Sanger sequencing (Table 2, Fig. 1b).  
Re-analyzing samples 











As ROBO1 and GREB1L seemed to be novel genes associated with bilateral kidney agenesis, we 
added these genes to our kidney-gene panel and re-analyzed samples from the eight fetuses with 
bilateral kidney agenesis that remained unsolved after the initial kidney gene-targeted analysis. We 
identified two ROBO1 variants in a fetus with bilateral kidney agenesis, hydrocephalus, and 
shortening of 1. metacarpals as well as another GREB1L variant in two fetal siblings with isolated 
bilateral kidney agenesis (Table 4). The father of these fetal siblings has unilateral kidney agenesis. 
Unfortunately, none of the parents were available for genetic testing. 
Kidney histology 
Hematoxylin and eosin staining of kidneys and liver of fetuses harboring likely deleterious variants 
were compared with a control fetus terminated 21+3. Fetus 9 and fetus 53 had similar histologic 
presentations of kidney and liver, showing a narrow abrupt nephrogenic zone, plenty of immature 
stroma, and medullary kidney cysts and hepatic ductal plate malformations (Fig. 2). In the 
remaining mutant fetuses, kidney histology fulfilled the criteria of kidney dysplasia and liver 
histology was unremarkable (data not shown) (10). 
Discussion 
In this cohort of fetuses in which previous genetic analyses had been unable to detect an underlying 
genetic cause, we applied kidney gene-targeted analyses and whole-exome sequencing (Table 2 and 
Table 3), revealing likely deleterious variants in 15 out of 62 (24%) fetuses, which is equivalent to 
11 of 56 (20%) families.  
Variants in TMEM67 (* 609884) 
 
The presence of similar kidney histology in two unrelated fetuses with TMEM67 variants supports 
the presence of a common underlying cause. Also, similarly to the findings in fetus 9 and fetus 53, 
it has been reported that most patients with TMEM67 variants have liver affections (Figure 2) (11). 











Gunay-Aygun et al. reported that TMEM67-associated disease may phenocopy the presentation of 
autosomal recessive polycystic kidney disease (ARPKD) (12). In fact, one of the fetuses with 
TMEM67 variants was suspected of ARPKD due to the combination of enlarged cystic kidneys and 
ductal plate malformation. However, the kidney cysts did not appear radically in the parenchyma as 
usually seen in ARPKD.  
TMEM67 encodes a cilia-related protein and is mutated in Meckel syndrome type 3 (# 607361), 
Joubert syndrome type 6 (# 610688), and nephronophthisis type 11 (# 613550) (13). As no 
structural cerebral abnormalities were observed in fetus 9 and fetus 53, the most likely clinical 
diagnosis is nephronophthisis type 11. Clinically, three forms of nephronophthisis have been 
described: an infantile, a juvenile, and an adolescent form. In the infantile form, end-stage renal 
disease is reached before the age of 2 years, and kidney histology is characterized by cortical 
microcysts and cystic dilatation of Bowman’s space (14). However, here we report two cases of 
severe nephronophthisis, histologically characterized by a narrow, abrupt nephrogenic zone, plenty 
of immature stroma, and medullary cysts, but not cystic dysplasia as seen in the lethal Meckel 
syndrome. This distinct presentation of nephronophthisis seems to be a novel prenatal form. 
Variants in PAX2 (* 167409) and HNF1B (* 189907)  
Transcription factor PAX2 is involved in capmesenchymal progenitor cell condensation, 
mesenchymal-epithelial transition, and cell polarization in the developing metanephric kidney (15). 
PAX2 variants cause autosomal dominant renal coloboma syndrome (# 120330) and have 
previously been reported to cause fetal bilateral kidney hypoplasia (16-18). Madariaga et al. 
reported pathogenic PAX2 variants in 4 of 75 fetuses with prenatally diagnosed severe kidney 
anomalies and pathogenic HNF1B variants in 12 of 90 fetuses with prenatally diagnosed severe 
kidney anomalies 16 . In consistency with their findings, we identified a PAX2 missense variant in 











dizygotic twins with kidney hypoplasia with cystic dysplasia from a family, suggesting autosomal 
dominant inheritance of the kidney affection. 
No HNF1B variants were identified in our cohort. However, we excluded two fetuses previously 
reported to have a HNF1B missense variant and a fetus known to harbor a 17q12 deletion 
encompassing the HNF1B gene identified by chromosomal microarray analysis (19,20). 
Variants in WNT4 (* 603490) 
Wnt4 is essential for generation of pretubular aggregates, leading to renal vesicles and further 
nephron morphogenesis (21-23). A Wnt4 knockout mouse model shows kidney hypodysplasia and 
defective sexual differentiation only in female mice (24, 25). Previously, WNT4 variants were 
reported to cause renal hypodysplasia in two brothers and unilateral kidney agenesis and 
uterovaginal agenesis in a hyperandrogenic female (26, 27). The male fetus 16 with a missense 
variant in WNT4 accordingly showed no defects in sexual differentiation. However, the kidney 
phenotype was more severe than previously reported. 
Variant in SIX2 (* 604994) 
Six2 expressed by the capmesencyme is important for maintaining the nephron progenitor cell 
population causing severe kidney hypoplasia in Six2 mutant mice (28, 29). SIX2 variants in humans 
have previously been reported to be a rare cause of isolated kidney anomalies. The human mutants 
have shown renal hypodysplasia, renal cysts, vesicoureteric reflux, and posterior urethral valve (18, 
30, 31). In accordance with this, fetus 19 showed a similar isolated kidney phenotype. 
Variant in RET (+ 164761) 
RET variants are a frequent cause of Hirschsprung disease and the underlying cause of multiple 
endocrine neoplasia type 2 (MEN2). RET variants have previously been reported in patients 
harboring both Hirschsprung disease and kidney anomalies or a combination of MEN2A and kidney 











anomalies (32, 33), which underlines that the same RET variant may cause multiple-organ 
manifestations. 
Heterozygosity for RET variants was previously reported in 9 of 29 fetuses with either bilateral or 
unilateral kidney agenesis. None of the parents were tested for the RET variants (34). In a 
subsequent study, RET variants were found in only 7 of 105 fetuses with severe bilateral kidney 
anomalies. In four of the seven fetuses, the variant’s parental origin was determined and identified 
in four healthy fathers (35). The paternally inherited RET variant c.3148C>T p.(Arg1050*) has 
previously been reported in a patient with Hirschsprung disease (36). Unfortunately, colon tissue 
from fetus 29 had not been archived, and it could therefore not be determined if enteric ganglia 
were present. Although we found no evidence of RET being imprinted 
(www.geneimprint.com/site/genes-by-species, igc.otago.ac.nz), it is possible that expression of the 
paternal allele is particularly important in early embryonic kidney development. 
Variants in ROBO2 (* 602431), SLIT2 (* 603746), and ROBO1 (* 602430) 
In mice, Slit2-Robo2 signaling is shown to restrict Gdnf-Ret signals to the site of the ureteric bud 
outgrowth preventing formation of multiple ureteric buds. Robo2 and Slit2 mice mutants show 
multiplex kidneys due to multiple ureteric bud formation. Multiplex kidneys are similar to duplex 
kidney, except that they result from fusion of multiple kidneys (37, 38). 











In humans, heterozygosity for ROBO2 variants has been reported as a rare cause of kidney 
anomalies (18, 39, 40). Recently, variants in the gene encoding the receptor ligand SLIT2 were also 
reported to cause kidney anomalies (39). It seems plausible that kidney development could be 
disrupted completely by the accumulated effect of a variant in the gene encoding the ligand and a 
variant in the gene encoding the receptor, as seen in fetus 43. Digenic combination of variants has 
previously been reported to exacerbate a kidney phenotype (41). However, it has to our knowledge 
not been reported within the CAKUT disease spectrum. In addition to bilateral kidney agenesis, 
fetus 43 was also diagnosed with a hypertrophic heart. Interestingly, Slit-Robo signaling has also 
been implicated in murine heart morphogenesis (38, 42). 
Compound heterozygosity for two novel ROBO1 variants was identified in three siblings; two 
fetuses with syndromic bilateral kidney agenesis and one live-born brother challenged in multiple 
ways (Fig. 1a and Table 3). Re-analysis of the samples identified another fetus with two ROBO1 
variants. This fetus also had syndromic bilateral kidney agenesis. 
ROBO1 variants have not previously been associated with human kidney anomalies. However, 
Robo1 has been shown to be expressed in the developing murine kidney along with the expression 
of the putative ligand, Slit2, and the receptor, Robo2 (43). Also, at least one Robo1 mice mutant 
develops multiplex kidneys (44). Furthermore, in situ hybridization analysis revealed Robo1 to be 
expressed in mice 14.5 dpc in a variety of tissues, including brain, spinal cord, eye, alimentary 
system, skeletal muscles, and limbs (www.eurexpress.org). Post-mortem examination of the two 
fetuses with biallelic ROBO1 variants revealed similar syndromic presentations. Also, one of the 
fetuses with ROBO1 variants was diagnosed with corpus callosum agenesis. Actually, the 
Drosophila robo1 was originally identified in a large-scale mutant screen of genes controlling 
midline axonal crossing in the central nervous system (45). Moreover, the live-born brother 











harboring both ROBO1 variants seemed to have a syndromic presentation with the brain, eye, and 
alimentary system being affected. 
Nicolaou et al. reported four patients with duplex collecting system, vesicoureteral reflux, posterior 
urethral valve, and kidney dysplasia, harboring candidate variants in ROBO1 for further research, 
but none of the patients were homozygous or compound heterozygous for ROBO1 variants (6). Our 
observations suggest that ROBO1 variants are implicated in a novel autosomal recessive syndrome 
that may include bilateral kidney agenesis. However, our findings do not support a disease-causing 
effect of heterozygosity for ROBO1 variants. 
Variants in GREB1L 
We identified a variant in GREB1L; yet the literature contained no indication of an association with 
kidney anomalies. However, we came across a report on a family in Iowa with kidney agenesis 
harboring a GREB1L variant. Our Family 1 (Fig. 1b and Table 3) and the Iowa family are reported 
by Brophy et al. who presents an argument for the implication of GREB1L in kidney 
morphogenesis through steroid hormone/retinoic acid receptor target activation (46). The 
combination of unilateral kidney agenesis and bilateral kidney agenesis in the same pedigree and 
the incomplete penetrance of autosomal dominant inherited kidney agenesis has previously been 
described (47). 
We subsequently added GREB1L to our kidney gene panel and identified another GREB1L variant 
in two fetal siblings with isolated bilateral kidney agenesis. Similarly to our first family harboring a 
GREB1L variant, one parent had unilateral kidney agenesis.  
 
In conclusion, targeted next-generation sequencing contributes substantially to identifying potential 
underlying causes of fetal kidney anomalies. We observed two unrelated fetuses with variants in 











TMEM67 affected by a prenatal form of nephronophthisis type 11 presenting with a similar distinct 
histological picture. Digenic combination of variants in ROBO2 and SLIT2 was associated with 
bilateral kidney agenesis and hypertrophic heart. Furthermore, we propose that ROBO1 variants are 
a cause of a novel autosomal recessive syndrome that may include bilateral kidney agenesis. This is 
the first time that SLIT-ROBO signaling is implicated in human bilateral kidney agenesis. 
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Prenatal ultrasound diagnoses in fetuses included in the study. 
Prenatal kidney diagnoses Number 
Bilateral kidney agenesis 14 
Bilateral MCDK †/kidney dysplasia/adysplasia/cystic kidneys 22 
Bilateral enlarged kidneys 2 
Bilateral hypoplastic kidneys 1 
Bilateral echogenic kidneys 16 
Bilateral duplex kidney 1 
Bilateral parenchymal thinning 1 
Unilateral echogenic kidney and oligohydramnios 1 
Unilateral echogenic kidney and contralateral agenesis 3 
Unilateral parenchymal thinning and contralateral echogenic kidney 1 
Total number of fetuses 62 
†multicystic dysplastic kidney 
 
  












Likely deleterious variants identified by our in-house-designed kidney gene-targeted analyses and 











































































































































































































































































































MCDK, multicystic dysplastic kidneys; MAF, minor allele frequency; TOP, termination of 
pregnancy; 1000Genomes, 1000 Genomes Project; ExAC, Exome Aggregation Consortium 
database; 2000DK, Whole-exome sequencing of 2,000 Danish individuals. 
† Fetus 11 and 12 were twins, the father has left unilateral kidney agenesis, the paternal grandfather 
had an unknown kidney disease. 
‡ The mother’s half-sister also had a TOP because of fetal bilateral kidney agenesis.  































































































































































































































































































































































Families subjected to whole-exome sequencing. Black-shaded symbols indicate bilateral kidney 
agenesis. Half-shaded symbol indicates unilateral kidney agenesis. Grey-shaded symbol indicates 
various features including delayed motor development, emotionally delayed development, mild 
dysmorphic features, and constipation requiring medication. 
 
 
Figure 2  
Hematoxylin- and eosin-stained mutant fetal kidneys and livers compared with a control fetus 
terminated at 21+3. Photomicrographs at lower magnification of the kidneys show a narrow and 
abrupt nephrogenic zone in fetus 9, fetus 53, and fetus 19, a disorganized nephrogenic zone with 
cysts in fetus 11 and fetus 12, and no nephrogenic zone in fetus 29. Photomicrographs at higher 
magnification of kidney medullas show plenty of immature stroma as well as cysts (cy) in fetus 9, 
fetus 53, and fetus 19. Furthermore, primitive ducts (pd) are seen in fetus 11, fetus 12, and fetus 19, 
immature glomeruli in fetus 19, and immature cartilage (ic) in fetus 29. Photomicrographs of livers 
show ductal plate malformations (dp) in fetus 9 and fetus 53. 
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